Novynette (Desogestrel, Ethinylestradiol)

Desogestrel, Ethinylestradiol, the active ingredients in Novynette, are a combined oral contraceptive presented as a 0.075 mg desogestrel/0.02 mg ethinylestradiol tablet for oral use. It prevents pregnancy and regulates menstrual cycles in women of reproductive age.

GNH USA supplies Novynette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Novynette is manufactured under EU GMP guidelines and is exported to multiple regions, ensuring consistent product quality and regulatory compliance.

Novynette, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy and manage menstrual disorders.

- Contraception: provides reliable prevention of pregnancy in women of reproductive age. - Menstrual cycle regulation: helps achieve regular, predictable menstrual periods. - Acne treatment: reduces acne lesions associated with hormonal fluctuations.

Novynette may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: occasional mild stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: mild to moderate intensity. - Breakthrough bleeding: spotting between periods. - Mood changes: irritability or mild mood swings. - Weight gain: slight increase in body weight.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Arterial thrombosis: stroke or myocardial infarction. - Hypertension: new‑onset high blood pressure. - Liver tumor: benign hepatic adenoma. - Severe allergic reaction: anaphylaxis or angioedema.

Before prescribing Novynette, clinicians should evaluate individual risk factors and counsel patients on safety considerations.

- Assess cardiovascular risk: review history of thrombosis, smoking, hypertension, and obesity. - Contraindicated in pregnancy: avoid use if pregnancy is known or suspected. - Monitor blood pressure: check for new or worsening hypertension. - Consider hepatic function: use with caution in liver disease. - Review concomitant medications: assess for drugs that may reduce efficacy. - Store at ambient temperature: keep below 25°C, protect from moisture and light.

Novynette can interact with several medicines, altering its effectiveness or increasing adverse risk.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may reduce contraceptive efficacy. - St. John's wort: strong CYP3A4 inducer that can lower hormone levels. - Anticoagulants (e.g., warfarin): may increase risk of thrombosis.

Moderate Interactions (Monitor Closely): - Antihypertensives: hormonal changes may affect blood pressure control. - Selective serotonin reuptake inhibitors: may exacerbate mood‑related side effects. - Diuretics: potential electrolyte disturbances when combined with hormonal therapy.